Skip to main content

Together we are beating cancer

Donate now

Cancer Research UK-funded research

Showing 12 out of 983 results
vaccine vials on a production line with a gloved hand reaching to grab one of them

Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer. Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

by Sophie Wedekind | News | 4 October 2024

4 October 2024

Caitlin, who was diagnosed with Ewing sarcoma this year and is going to take part in our INTER-EWING-1 trial.

INTER-EWING-1, the largest and most ambitious study ever conducted into Ewing sarcoma, could transform how we treat the disease, which mainly affects children and young people.   INTER-EWING-1, the largest and most ambitious study ever conducted into Ewing sarcoma, could transform how we treat the disease, which mainly affects children and young people.  

by Momoko Bowles | Analysis | 25 September 2024

25 September 2024

CT scan of a glioblastoma brain tumour highlighted in one section of the brain.

Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments. Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments.

by Sadaf Shafaghmotlagh | News | 24 September 2024

24 September 2024

A sample of a mouse model of a tumour seen through team Rosetta's tools.

Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good. Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good.

by Tim Gunn | In depth | 24 September 2024

24 September 2024

Researchers working in the lab at CRUK's Scotland Institute

Over the last financial year, Cancer Research UK has made significant steps towards achieving its vision of bringing about a world where everyone can live longer, better lives, free from the fear of cancer, as outlined in the charity’s latest Annual Report and Accounts, which were published today. Over the last financial year, Cancer Research UK has made significant steps towards achieving its vision of bringing about a world where everyone can live longer, better lives, free from the fear of cancer, as outlined in the charity’s latest Annual Report and Accounts, which were published today.

by Cancer Research UK | News | 11 September 2024

11 September 2024

A medical professional drawing a dose of a vaccine from a vial with a syringe

LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types. LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types.

by Tim Gunn | News | 10 September 2024

10 September 2024

scientists in a lab

Cancer Research UK and LifeArc are investing £27m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers. Cancer Research UK and LifeArc are investing £27m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers.

by Sophie Wedekind | News | 5 September 2024

5 September 2024

An image of Faye lying down in the proton beam therapy machine next to an image of her in hospital making decorations for a fundraising sale.

Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like. Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like.

by Tom Bourton, Tim Gunn | Personal stories | 3 September 2024

3 September 2024

Microscopy image of Hodgkin's lymphoma

Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters. Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters.

by Cancer Research UK | In depth | 3 September 2024

3 September 2024

Two cancer researchers looking at a cell image on screen

For Childhood Cancer Awareness Month, we're highlighting some our most important research into children's and young peoples' cancers over the past year. For Childhood Cancer Awareness Month, we're highlighting some our most important research into children's and young peoples' cancers over the past year.

by Momoko Bowles | Analysis | 1 September 2024

1 September 2024

A woman reading a cancer information limit while waiting to see the doctor.

Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund. Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund.

by Tim Gunn | News | 15 August 2024

15 August 2024

Brain scans

Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients. Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients.

by Tim Gunn | Analysis | 7 August 2024

7 August 2024